These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31063075)

  • 1. Re: Fecal Transplant Modifies Urine Chemistry Risk Factors for Urinary Stone Disease.
    Assimos DG
    J Urol; 2019 Aug; 202(2):205. PubMed ID: 31063075
    [No Abstract]   [Full Text] [Related]  

  • 2. Fecal transplant modifies urine chemistry risk factors for urinary stone disease.
    Stern JM; Urban-Maldonado M; Usyk M; Granja I; Schoenfeld D; Davies KP; Agalliu I; Asplin J; Burk R; Suadicani SO
    Physiol Rep; 2019 Feb; 7(4):e14012. PubMed ID: 30789675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.
    Assimos DG
    J Urol; 2020 Jun; 203(6):1056-1057. PubMed ID: 32155362
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation.
    Ogawa Y; Hatano T
    Int J Urol; 1996 Sep; 3(5):356-60. PubMed ID: 8886911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
    Lewandowski S; Rodgers AL
    Clin Chim Acta; 2004 Jul; 345(1-2):17-34. PubMed ID: 15193974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of urinary pH and acid-base balance on the formation of calcium oxalate stone].
    Iida S
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):33-40. PubMed ID: 2046198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients.
    Siener R; Glatz S; Nicolay C; Hesse A
    Eur Urol; 2003 Oct; 44(4):467-74. PubMed ID: 14499683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C; Larsson L; Tiselius HG
    Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxalate loading test for outpatients with calcium oxalate stones].
    Kato M
    Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Sanguankeo A
    Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate urolithiasis.
    Rodgers A
    Urol Res; 1999; 27(1):77-81. PubMed ID: 10092157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.